| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |